-
1.(3-(4-(AMINOMETHYL)PHENOXY OR PHENYLTHIO)AZETIDIN-1-YL)(5-PHENYL-1,3,4-OXADIAZOL-2-YL)METHANONE COMPOUNDS 失效
标题翻译: (3-(4-(氨基甲基)苯氧基或苯基)亚甲基-1-基)(5-苯基-1,3,4-氧杂双环-2-基)甲酮化合物公开(公告)号:US20120010189A1
公开(公告)日:2012-01-12
申请号:US13176554
申请日:2011-07-05
申请人: Susanne Doris Margit Bökman-Winiwarter , Marlene FREDENWALL , Carl Anders Hogner , Lars Anders Mikael Johansson , Robert Andrew Judkins , Lanna Li , Björn Christian Ingvar Löfberg , Sverker Von Unge
发明人: Susanne Doris Margit Bökman-Winiwarter , Marlene FREDENWALL , Carl Anders Hogner , Lars Anders Mikael Johansson , Robert Andrew Judkins , Lanna Li , Björn Christian Ingvar Löfberg , Sverker Von Unge
IPC分类号: A61K31/4245 , C07D295/155 , A61P3/04 , C07D413/12 , C07D205/04 , C07D413/14 , C07D295/096
CPC分类号: C07D413/06 , A61K31/4245 , C07D413/14
摘要: Disclosed herein are azetidinyl compounds of formula I, as described herein, pharmaceutical compositions comprising an azetidinyl compound, and a method of using an azetidinyl compound in the treatment or prophylaxis of a melanin-concentrating hormone related disease or condition.
摘要翻译: 本文公开的是式I的氮杂环丁烷基化合物,如本文所述,包含氮杂环丁烷基化合物的药物组合物和使用氮杂环丁烷基化合物在治疗或预防黑色素浓缩激素相关疾病或病症中的方法。